SCHEMBL7520034

SCHEMBL7520034

[CH2]CCc1ccc(CO)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
CHKA P35790 1/20 0.45
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
CA2 P00918 3/20 0.40
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA5A P35218 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
VHL P40337 1/20 0.39
ELOC Q15369 1/20 0.39
ELOB Q15370 1/20 0.39
LTA4H P09960 1/20 0.39
ESR1 P03372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2745550 0.85 GFER (0.42) CA2LTA4HESR1ESR2TDP1
SCHEMBL3360491 0.83 CA2 (0.59) TSHRCA2CA12CA1CA4
SCHEMBL7539245 0.82 CHKA (0.58) TSHRCHKAPRSS1PRSS2PRSS3
SCHEMBL41775 0.78 TSHR (0.67) TSHRCHKAPRSS1PRSS2PRSS3
SCHEMBL503866 0.78 ESR1 (0.68) CA2LTA4HESR1ESR2TDP1
SCHEMBL25301605 0.77 TSHR (0.50) TSHRCHKAPRSS1PRSS2PRSS3
SCHEMBL40703 0.77 CA2 (0.65) TSHRCHKAPRSS1PRSS2PRSS3
SCHEMBL2686386 0.77 TSHR (0.50) TSHRCHKAPRSS1PRSS2PRSS3
Formaldehyde SCHEMBL8673672 0.76 TSHR (0.56) TSHRCHKAPRSS1PRSS2PRSS3
SCHEMBL7771585 0.75 ENPP2 (0.47) TSHRPRSS1PRSS2PRSS3DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0584223-B1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMA (US) 1999-08-11 EP claimed
US-5620971-A Biologically active acylated amino acid derivatives VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-04-15 US claimed
EP-0584223-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1994-03-02 EP claimed
WO-1992019593-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1992-11-12 WO claimed
CN-1494906-A Application of compound in preparation of medicine for preventing and curing multiple drug resistance ��̩��˹ҩ��ɷ����޹�˾ 2004-05-12 CN disclosed
CN-1367678-A Method of treating hair loss using ketoamides PROCTER & GAMBLE (US) 2002-09-04 CN disclosed
CN-1086386-C Multi-drug resistance modifiers VERTEX PHARMA (US) 2002-06-19 CN disclosed
EP-1179529-A1 NOVEL HYDROXAMIC ACID DERIVATIVES Daiichi Fine Chemical Co., Ltd. (JP) 2002-02-13 EP disclosed
CN-1320028-A Method of treating hair loss using sulfonamides PROCTER & GAMBLE (US) 2001-10-31 CN disclosed
EP-1117371-A2 METHOD OF TREATING HAIR LOSS USING KETOAMIDES The Procter & Gamble Company (US) 2001-07-25 EP disclosed
EP-1117372-A2 METHOD OF TREATING HAIR LOSS USING SULFONAMIDES THE PROCTER & GAMBLE COMPANY (US) 2001-07-25 EP disclosed
EP-1101492-A1 NOVEL REMEDIES FOR ALLERGIC DISEASES FUJI YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 2001-05-23 EP disclosed
EP-1038864-A1 NOVEL METALLOPROTEINASE INHIBITORS FUJI YAKUHIN KOGYO KABUSHIKI KAISHA (JP) 2000-09-27 EP disclosed
WO-2000018358-A2 METHOD OF TREATING HAIR LOSS USING KETOAMIDES THE PROCTER & GAMBLE COMPANY (US) 2000-04-06 WO disclosed
WO-2000018361-A2 METHOD OF TREATING HAIR LOSS USING SULFONAMIDES THE PROCTER & GAMBLE COMPANY (US) 2000-04-06 WO disclosed
CN-1202104-A Methods and compositions for stimulating neurite growth VERTEX PHARMA (US) 1998-12-16 CN disclosed
CN-1088577-A Novel multi-drug resistance modifiers VERTEX PHARMA (US) 1994-06-29 CN disclosed